What is the most likely cause of a rash under a menstrual pad and how should it be treated?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: February 28, 2026View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Menstrual Pad Rash: Cause and Treatment

A rash under a menstrual pad is most commonly caused by irritant contact dermatitis from moisture, friction, and occlusion, though allergic contact dermatitis to pad components (particularly acrylates, colophony/rosin, or fragrances) should be considered if the rash recurs with specific products.

Most Likely Causes

Irritant Contact Dermatitis (Primary Cause)

  • Moisture and occlusion from prolonged pad contact create an environment that disrupts the skin barrier, leading to erythema, maceration, and inflammation 1
  • Friction and pressure from the pad against vulvar skin exacerbates irritation, particularly during movement 1
  • This mechanism mirrors other occlusive dermatoses and does not require specific allergen exposure 1

Allergic Contact Dermatitis (Secondary Consideration)

  • Acrylates in absorbent gel materials can cause severe allergic reactions if incompletely polymerized; patients may show dramatic patch test positivity 2, 3
  • Colophony (rosin) in adhesive components has been documented to cause marked sensitivity (3+ reactions on patch testing) 4
  • Fragrances including α-isomethyl ionone, benzyl salicylate, hexyl cinnamaldehyde, and heliotropine can exceed acceptable exposure levels and induce sensitization, particularly in scented products 5
  • Allergic reactions typically recur with re-exposure to the same product brand 4, 3

Infectious Causes (Must Rule Out)

  • Candidiasis presents with thick white discharge, severe vulvar itching, and vaginal pH ≤4.5; diagnosis requires KOH preparation showing yeast or pseudohyphae 1, 6, 7
  • Bacterial vaginosis causes homogeneous white discharge, fishy odor (positive whiff test), clue cells, and vaginal pH >4.5 6, 7, 8
  • Trichomoniasis produces frothy green-yellow discharge with marked itching and pH >4.5; wet mount shows motile trichomonads 6, 7, 8

Diagnostic Algorithm

Step 1: History

  • Temporal relationship: Does the rash appear only during pad use and resolve when pads are discontinued? 4, 3
  • Product specificity: Does switching pad brands change symptoms? Recurrence with the same brand suggests allergy 4, 3
  • Associated symptoms: Vaginal discharge, odor, or itching suggests infection rather than contact dermatitis 6, 7

Step 2: Physical Examination

  • Distribution: Rash confined to areas of pad contact (labia, perineum) suggests contact dermatitis; vaginal involvement suggests infection 1
  • Morphology: Erythema with maceration indicates irritant dermatitis; vesicles or sharp demarcation suggest allergic contact dermatitis 1

Step 3: Office Testing (If Discharge Present)

  • Vaginal pH: >4.5 indicates bacterial vaginosis or trichomoniasis; ≤4.5 suggests candidiasis 6, 7, 8
  • Whiff test: Fishy odor with 10% KOH confirms bacterial vaginosis or trichomoniasis 6, 7, 8
  • Wet mount: Identifies clue cells (bacterial vaginosis), motile trichomonads (trichomoniasis), or yeast/pseudohyphae (candidiasis) 6, 7

Step 4: Patch Testing (If Allergic Dermatitis Suspected)

  • Perform patch testing with the actual pad (moistened inner and outer surfaces) and standard allergen series including acrylates, colophony, and fragrance mix 4, 2, 3
  • Test only if rash recurs with specific products or persists despite conservative management 4, 3

Treatment Approach

First-Line: Conservative Management for Irritant Dermatitis

Immediate measures:

  • Discontinue the current pad and switch to unscented, hypoallergenic products without gel absorbents 5
  • Avoid moisture and occlusion: Change pads every 3-4 hours; avoid overnight use of thick pads 1
  • Gentle cleansing: Use mild soap and warm water; avoid hot showers, excessive soap, and douching 1, 6, 8

Topical therapy:

  • Barrier protection: Apply petrolatum to affected areas to prevent moisture evaporation and provide a protective film 1
  • Mild topical corticosteroid: Hydrocortisone 1% cream applied to affected areas 3-4 times daily for erythema and inflammation 9
    • Clean area with mild soap, rinse thoroughly, and pat dry before application 9
    • Avoid prolonged use (>7 days) without dermatology supervision to prevent skin atrophy 1

Avoid:

  • Greasy occlusive creams that may worsen folliculitis 1
  • Alcohol-containing lotions or gels that cause further drying 1
  • Manipulation or scratching due to infection risk 1

Treatment for Confirmed Infections

Candidiasis (if pH ≤4.5, yeast on KOH prep):

  • Clotrimazole 1% cream 5g intravaginally for 7-14 days (treats vaginal infection and relieves external itching) 1, 10
  • Alternative: Fluconazole 150mg oral single dose 1, 7
  • Topical azoles achieve 80-90% symptom relief and negative cultures 1

Bacterial vaginosis (if ≥3 Amsel criteria present):

  • Metronidazole 500mg orally twice daily for 7 days (95% cure rate) 6, 7, 8
  • Avoid alcohol during and for 24 hours after treatment 6
  • Partner treatment is not recommended 6, 7, 8

Trichomoniasis (if motile trichomonads on wet mount or positive NAAT):

  • Metronidazole 2g oral single dose (90-95% cure rate) 6, 7, 8
  • Sexual partner must be treated simultaneously to prevent reinfection 6, 7, 8

Escalation for Persistent or Severe Cases

If no improvement after 7 days of conservative management:

  • Refer to dermatology for patch testing to identify specific allergens 4, 2, 3
  • Consider short-term topical steroid (prednicarbate cream 0.02%) under dermatology supervision for severe inflammation 1

For pruritus grade 2-3:

  • Oral H1-antihistamines (cetirizine, loratadine, or fexofenadine) for symptom relief 1

Common Pitfalls

  • Do not assume all pad rashes are simple irritation: Recurrence with the same product brand strongly suggests allergic contact dermatitis requiring patch testing 4, 3
  • Do not overlook infection: Always measure vaginal pH and perform wet mount if discharge is present; treating contact dermatitis alone will fail if infection coexists 6, 7
  • Do not use topical steroids for prolonged periods without supervision: Risk of perioral dermatitis and skin atrophy 1
  • Do not recommend OTC antifungals without confirming candidiasis: Inappropriate use delays diagnosis of other etiologies and worsens outcomes 1
  • Fragrance allergens in scented pads can exceed safe exposure levels: Women should be counseled to avoid scented products if sensitization is suspected 5

References

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Contact dermatitis to incontinency pads in a (meth)acrylate allergic patient.

American journal of contact dermatitis : official journal of the American Contact Dermatitis Society, 2002

Research

Acrylate Systemic Contact Dermatitis.

Dermatitis : contact, atopic, occupational, drug, 2015

Research

Allergic contact dermatitis to a sanitary pad.

The Australasian journal of dermatology, 2004

Research

Quantitative risk assessment of allergens leaching from menstrual hygiene products.

Regulatory toxicology and pharmacology : RTP, 2022

Guideline

Vaginitis Diagnosis and Treatment

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Guideline

Management of Vaginal Discharge in Women

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Evaluation and Management of Vaginal Odor in Pregnancy

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2026

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.